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Abstract
Background: The populations of the Arabian Peninsula remain the least represented in public genetic databases,
both in terms of single nucleotide variants and of larger genomic mutations. We present the first high-resolution
copy number variation (CNV) map for a Gulf Arab population, using a hybrid approach that integrates array genotyping
intensity data and next-generation sequencing reads to call CNVs in the Qatari population.
Methods: CNVs were detected in 97 unrelated Qatari individuals by running two calling algorithms on each of two
primary datasets: high-resolution genotyping (Illumina Omni 2.5M) and high depth whole-genome sequencing
(Illumina PE 100bp). The four call-sets were integrated to identify high confidence CNV regions, which were
subsequently annotated for putative functional effect and compared to public databases of CNVs in other populations.
The availability of genome sequence was leveraged to identify tagging SNPs in high LD with common deletions in this
population, enabling their imputation from genotyping experiments in the future.
Results: Genotyping intensities and genome sequencing data from 97 Qataris were analyzed with four different
algorithms and integrated to discover 16,660 high confidence CNV regions (CNVRs) in the total population,
affecting ~28 Mb in the median Qatari genome. Up to 40 % of all CNVs affected genes, including novel CNVs
affecting Mendelian disease genes, segregating at different frequencies in the 3 major Qatari subpopulations,
including those with Bedouin, Persian/South Asian, and African ancestry. Consistent with high consanguinity
levels in the Bedouin subpopulation, we found an increased burden for homozygous deletions in this group. In
comparison to known CNVs in the comprehensive Database of Genomic Variants, we found that 5 % of all CNVRs
in Qataris were completely novel, with an enrichment of CNVs affecting several known chromosomal disorder loci and
genes known to regulate sugar metabolism and type 2 diabetes in the Qatari cohort. Finally, we leveraged the
availability of genome sequence to find suitable tagging SNPs for common deletions in this population.
Conclusion: We combine four independently generated datasets from 97 individuals to study CNVs for the first time
at high-resolution in a Gulf Arab population.
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Background
The Qatari peninsula, located on the eastern coast of the
Arabian Peninsula, is at a major crossroads of human
migration [1]. This geographical location has led to
several waves of settlement over the past millennia, creating
unique ethnic ancestries that form the present day’s popula-
tion. We previously described 3 major genetic subgroups of
Qataris, including those of Bedouin (Q1), Persian-South
Asian (Q2), and African ancestry (Q3) [2–4]. Although all
three share a common environment, there is a significant
level of segregation among the populations, with a higher
level of consanguinity observed in Q1 and to a certain
extent Q2, over Q3, leading to the formation of 3 distin-
guishable genetic pools. Exome sequencing has shown that
each subpopulation has different predispositions to various
Mendelian diseases, an observation with consequences
for public health planning in the context of pre-existing
premarital screening programs [5].
Whereas classic Mendelian disorders are generally de-
fined by single nucleotide polymorphism’s (SNPs), there is
increasing evidence that copy number variation (CNV)
also play a significant role in disease [6–9]. CNVs in the
0.5 Kb to several Mb size range account for up to 4 % of
the human genome, and generally behave like SNPs – hav-
ing a detectable minor allele frequency, existing in linkage
disequilibrium (LD) with neighboring SNPs on variable
length haplotypes and being inherited in Mendelian fashion
[7, 10]. Unlike SNPs, however, CNVs could be extremely
multi-allelic (>3 segregating alleles), and may therefore
contribute to continuous traits by causing a spectrum
of variation in gene dosage [11]. Though common CNVs
have traditionally shown relatively poor association with
common disease [12], intermediate frequency (1-10 %)
and rare (<1 %) but recurrent CNVs cause a variety of dis-
orders, including extreme obesity, congenital heart disease,
and a wide spectrum of neurological and developmental
disorders [13–24].
Because of the high degree of consanguinity in the
Qatari population, it is likely that CNVs, alongside SNPs
and indels, play a role in the inherited disease risk burden
in this population [5, 10, 25]. Further, because of the cul-
tural segregation of the major genetic groups (Q1, Q2, and
Q3) within the Qatari population, it is likely that there are
novel CNV Regions (CNVRs) specific to each group,
representing distinct subpopulation histories and risk
for disease. In the context of these considerations, we
have used complete genome sequencing along with SNP
microarray analysis of 97 Qataris (57 Q1, 20 Q2, 20
Q3) to assess the spectrum of CNVs and CNVRs in the
Qatari population, representing the first high-resolution,
genome-wide assessment of the burden of small to
medium-sized chromosomal deletions and duplications in
a Middle Eastern Arab population. This work on the CNV
class of mutations is complementary to a study from our
group describing ancestry, polymorphisms and disease
susceptibility from the single nucleotide variant class of
mutations from these same individuals [26].
Results
Detection of CNVs
To identify CNVs in the Qatari population, primary data
was obtained from arrays and whole-genome sequencing
sources, and then called and integrated as described in
methods (Fig. 1). Briefly, CNV calls were first generated in
the 100 individuals from Illumina’s Omni2.5 M array inten-
sity data using both cnvPartition (Illumina’s proprietary
Beadstudio plug-in) and QuantiSNP [27], and, separately,
from NGS using cn.MOPS [28], in addition to CNV calls
provided by Illumina from WGS data. Altogether, there
were two primary datasets called by 2 independent algo-
rithms each, and all 4 subsequently combined for final
CNV calls as described below.
Preliminary qualitative inspection of the raw distribu-
tion of all CNVs in the 100 individuals revealed 3 outlier
samples with a large excess of CNV calls (Additional
file 1: Figure S1). These individuals significantly skewed
the average number of CNVs in the population (Additional
file 1: Table S1) and were therefore removed from further
consideration, yielding a cohort of 97 individuals in whom
all subsequent analysis was conducted.
The 4 platforms initially identified a total of 536,889
CNVs from all 4 algorithms in the 97 individuals, including
119,236 putative deletions [copy number class (CN) 0 or 1]
and 417,653 putative duplications (CN 3 or 4+; Table 1).
The excess of duplications over deletions is largely a result
of CNVs provided by Illumina’s proprietary WGS calls,
which reported 314,656 duplications and 49,177 deletions,
with no homozygous deletions (CN 0) called in the 97
samples.
In order to enhance specificity, we devised an ap-
proach to integrate CNV calls across all 4 platforms, re-
quiring a CNV to be observed at least twice to be
retained (Fig. 1). In this step, each of the 536,889 raw,
high quality CNVs was first compared to all other CNVs
detected by any of the four platforms within the same
individual file, and those observed twice (detected by >1
algorithm in the same individual) were included in the
‘final’ variant file for that individual. All CNVs observed
only once were then compared across all other individ-
uals to look for a second occurrence in another individ-
ual. If found, that CNV was retained in the individual’s
‘final’ variant file, or otherwise discarded. This allowed
for significant refinement of the list of CNVs in the
population, eliminating all singleton CNV occurrences
in the population – usually the most enriched for spuri-
ous calls. Using this approach, the average individual’s
‘final’ genome had 1824 high-confidence CNVs, com-
prising 120 homozygous deletions, 628 single-copy
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deletions, 801 single-copy duplications and 275 ampli-
fications (Table 1).
During this filtration and integration process, all CNVs
were concurrently curated to re-define breakpoints based
on the source of CNVs. Briefly, whenever NGS-derived
CNVs overlapped array-CNVs, we used the NGS’s higher-
resolution breakpoints to define the start and/or end
coordinate of the duplication or deletion. Wherever two
CNVs detected from the same platform were observed to
overlap, the narrower breakpoints were chosen, yielding a
shorter, more conservative CNV call. After this curation,
the ‘final’ CNV content in the average Qatari genome af-
fected a total of 29.9 × 106 non-redundant bases (Table 1).
This is slightly lower than previously published estimates
[22] and may reflect the strict filtration and breakpoint
definition thresholds applied in this study.
The median Qatari genome, based on the four different
algorithms and platforms, contained 1815 high-resolution
CNVs, covering an estimated total of 27,991,857 bp
(Table 1). These were distributed into the 4 CN classes:
CN–0 (homozygous deletions), 121 CNVs, affecting
1.1 Mb; CN–1 (single-allele deletions), 622 CNVs, affect-
ing 5.8 Mb; CN–3 (single-allele duplication), 801, affecting
16.8 Mb; and CN–4+ (amplification), 271, affecting
4.1 Mb. The excess number and larger size of duplications
could be explained by a higher proportion of duplications
detected by our NGS-CNV callers (Table 1), and may re-
flect a combination of reads mapping to segmental dupli-
cations and the fact that we included all multi-allelic
CNVs with more than 4 copies in the same amplification
group [11]. Of 1815 CNVs, 1381 (76.1 %) were de-
tected by NGS alone, 122 (6.7 %) were detected by
array technology only, and 312 (17.2 %) were detected
by both, suggesting that the two datasets may both be
beneficial in representing the total CNV content
within an individual, and relying on only one may not
be sufficient to cover all variation (Additional file 1:
Figure S2).
123,220 165,746 4,703 21,100





Split to 97 individuals
Merge into population-specific CNV regions
Analysis
Illumina cn.MOPS CNVPart QSNP
Final individual “processed” CNV files
Keep any CNV detected by >1 platform
Keep any CNV detected in>1 individual in the population
Discard all one-offs (singletons not observed elsewhere in the population or the world)
Platform-specific CNV Detection Step
CNV preprocessing and detection
CNVs divided into individual file for each person
x97 files
Filtering and QC
Fig. 1 CNV analysis strategy. CNV detection in Qataris was assessed at two tiers. First, CNVs were called in 100 individuals using two algorithms
each, on two primary input datasets: genotyping array (OMNI2.5 M) and next-generation whole genome sequencing reads (Illumina PE 100 bp,
Mean Depth: 37X). A size cut-off of at least 5 consecutive probes for genotyping data and at least 5 consecutive windows for whole genome
sequencing data was used to increase specificity (see Methods). Three samples with an unusually high number of CNVs were first removed from
the population (see Additional file 1: Figure S1). In the second step, high-quality CNVs from the remaining 97 subjects called by all 4 platforms
were distributed into 97 individual files. CNVs were first compared intra-individuals and retained if observed by more than one algorithm. If no
overlap was detected within the individual, the CNV was compared inter-individuals to detect a second occurrence in the remaining 97 individuals.
CNVs observed only once in the entire sample were discarded. CNVs passing these filters were merged across the population to generate population
level CNV regions (CNVRs), which were taken into the detailed analysis steps. *Denotes data was provided as-is from proprietary Illumina Genome
Network sequencing pipeline without the ability of the user to alter parameters
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Total size of all non-overlapping
CNVRs in the subpopulation
Array Data
QSNP 56,135 7,435 23,497 30,932 16,767 8,436 25,203 - -
CNVPart 16,895 1,026 3,906 4,932 9,527 2,436 11,963 - -
Sequencing Data
cn.MOPS 100,026 2,097 32,098 34,195 50,080 15,751 65,831 - -
IL-NGS 363,833 - 49,177 49,177 213,435 101,221 314,656 - -
Total CNVs by CN Class 536,889 10,558 108,678 119,236 289,809 127,844 417,653 - -
CNVs per individual
Average/individual 1,824 120 628 748 801 275 1,076 - -
Median/individual 1,815 121 622 743 801 271 1,072 - -
Average size by class/
individual
29,934,170 1,131,273 5,928,199 7,059,472 18,400,102 4,474,596 22,874,698 - -
Median size by class/
individual
27,911,587 1,087,616 5,787,942 6,875,558 16,889,655 4,146,374 21,036,029 - -
CNV Regions (CNVRs) by genetic subpopulation
Q1 5,241 149 2,534 2,683 1,480 270 1,750 808 85,705,083
Q2 4,176 116 1,909 2,025 1,242 273 1,515 636 65,814,099
Q3 4,641 101 2,283 2,384 1,316 304 1,620 637 65,851,402
Total across
subpopulations
14,058 366 6,726 7,092 4,038 847 4,885 2,081 -
Average size of CNVRs
within each class
15,462 4,187 8,604 8,376 20,101 10,669 18,457 32,561 -
aFour different algorithms were applied to detect CNVs in 97 individuals. For analysis of the Illumina Omni2.5 M Array Data, QuantiSNP (QSNP) [27] and Illumina’s cnvPartition (CNVPart) were used; for next-generation-
sequencing (NGS) genomic data, cn.MOPS (CNMOPS) [28] was used with additional CNV calls provided by Illumina’s genome-sequencing service (IL-NGS). Shown are the numbers of CNVs detected by each algorithm
in each copy number class, along with the total number of CNVs detected by copy number (CN) class and by CNV platform. CN (Copy number) class 0 = homozygous deletions; CN 1 = heterozygous deletions; CN
3 = single-allele duplication; CN 4 + = amplifications. Total deletions and duplications are a sum of CN classes 0, 1 and 3, 4+, respectively. Total CNVs and size are shown by platform and by class. As expected,
array-based methods generated fewer but larger CNVs, whereas NGS based methods generated more but, on the average, smaller CNVs. The number of CNVs per individual is shown for the average and median
individual amongst 97 individuals who passed the QC. CNV counts are shown by CN class. Additionally, the size of genomic content that is altered by CNVs in each CN class in the average and median individuals
are provided. As described in Methods, these CNVs were merged across individuals within the same subpopulation to arrive at subpopulation level CNV Regions (CNVRs). The number of CNVRs within each sub-
population is given for each CN class, and the size of the average CNVR within each class is also shown. Within a population, there are sites that sometimes contain both deletions and duplications in different individuals; these
are tallied in a column labeled ‘polymorphic’ CNVRs and represent about 15 % of all CNVRs within a given population. Finally, the total size of all non-overlapping CNV regions within each subpopulation is shown













CNV distribution in Qatari subpopulations
The 97 individuals were examined in the context of the
three Qatari ancestral subpopulations (57 Q1 – Bedouin
ancestry, 20 Q2 – Persian ancestry, and 20 Q3 – African
ancestry). In order to evaluate the accuracy of CNV calls,
we initially used the CNVs detected across all 97 individ-
uals and performed principle component analysis. This
analysis separated individuals previously known to be-
long to Q1, Q2 and Q3 from genotyping data into their
three respective subpopulations based on CNV sharing.
The PCA plot showed some level of overlap between Q1
and Q2 clusters, which could be a result of admixture
and our assignment of ethnicity based on only 65 % of 48
SNPs (Additional file 1: Figure S3 and details in methods),
with Q3 (with the exception of 1 individual) being the
most clearly distinct subpopulation. These results are
similar to those obtained from a PCA plot using only
SNPs, as published in [29]. The similarity of clustering
using PCA on CNV and genotyping data in 97 Qataris is
consistent with a previous report demonstrating that PCA
analysis based on high quality CNVs yields similar clusters
to one based on SNPs from the same individuals [30].
We then inspected the distribution of CNVs by fre-
quency in each class per individual (Additional file 1:
Figure S4), and observed that, on average, individuals
from all three subpopulations had a similar range of
CNVs in all four classes. However, in order to detect if
the three genetic subpopulations may have differences in
the distribution by number or size of CNVs in each CN
class, probability curves were generated of CN number
(Fig. 2a-d) and total size affected (Fig. 2e-h) within each
CN class for each of the 3 subpopulations (as described
in Methods). For CN class 0 (homozygous deletions),
these occurred at a significantly higher frequency in Q1
and Q2 over Q3 (p = 1.8x10−6 and 1.2 × 10−4, respectively).
However, this trend was reversed in amplifications (CN
4+), which were found at a higher rate in Q3 than either
Q1 or Q2 (p = 1.5 × 10−5 and 0.006, respectively). These
observations may reflect higher consanguinity rates in
recent generations within Q1 and Q2, where enrichment
in homozygous deletions (Fig. 2a) but depletion of amplifi-
cations vs Q3 (Fig. 2d) suggests that homozygous deletions
are more harmful than multi-allelic, runaway duplications,
and may therefore have been purged from Q3 by purifying
selection over population history but only recently arisen
in Q1 and Q2. This possibility is supported by two further
observations. First, for single-copy deletions (CN 1), we
observed a significantly higher number in Q3 (p = 3 × 10−7
and 1 × 10−7 vs Q1 and Q2, respectively) despite the deple-
tion of homozygous deletions relative to the other two
subpopulations, suggesting higher diversity and less
consanguinity in recent generations among Q3 Qataris
vs Q1 or Q2. Second, for Q1, we observe a slightly longer
tail in the size of the genome affected by single copy
deletions (Fig. 2f) despite reduced number of CNVs in
that class compared to Q3, suggesting these alleles are lar-
ger in size and possibly more recent or more deleterious,
causing this tail of large CNVs to be absent in the homo-
zygous subset of CNVs in Q1 (Fig. 2e).
Genomic impact of CNVRs in the genetic subpopulations
In order to evaluate the impact of duplications and dele-
tions on each subpopulation individually, we first separately
merged deletions and duplications within each group to de-
tect subpopulation-specific CNV Regions (CNVRs). There
were a total of 16,660 CNVRs in the 3 subpopulations;
12,709 (76.2 %) came from NGS data only, 1976 (11.9 %)
from array only, and 1975 (11.9 %) from both platforms
combined (Additional file 1: Figure S2B; see Additional file
1: Additional Data). When deletions and duplications at
the same locus (polymorphic CNVRs) were combined,
there were a total of 14,058 CNVRs, including 7092 dele-
tions, 4885 duplications, and 2081 polymorphic CNVRs
(Table 1).
In the Q1 subpopulation, there were a total of 5241
CNVRs of all CN classes, affecting 85.7 Mb of genomic
content; in Q2, 4176 CNVRs affecting 65.8 Mb, and in
Q3 4641 CNVRs affecting 65.8 Mb (Table 1). The excess
number and cumulative size of CNVRs in Q1 is likely
due to the ~3-fold higher number of individuals studied.
As expected, the majority of CNVRs were sub-
population specific, with 3624, 3242 and 3633 CNVRs at
low-frequency (affecting 1 to 20 % of individuals) in Q1,
Q2 and Q3 respectively, vs only 2657, 1715 and 1789
that were common (affecting >20 %).
Functional effect of CNV-affected genes in Q1, Q2 and Q3
In order to evaluate the functional effect of deletions
and duplications separately on the entire population, the
polymorphic CNVRs were separated into their respective
CN classes (Table 2). In total, 16,660 CNVRs were ob-
served in all four CN classes in the three subpopula-
tions, including 6281 in Q1, 4957 in Q2 and 5422 in Q3.
In all three subpopulations, ~39-40 % of all CNVRs were
genic (2491 in Q1, 1995 in Q2 and 2085 in Q3), 4-5 %
affected microRNA loci (229 in Q1, 183 in Q2 and 180
in Q3), 13-15 % affected promoter sites (831 in Q1,
647 in Q2 and 660 in Q3) and ~38-40 % affected tran-
scription factor binding sites (2573 in Q1, 1879 in Q2
and 2065 in Q3). We focused on genic CNVs in subse-
quent analysis to determine the extent of CNV impact
on genes and pathways and population burden for
genetic disease.
Genic pathway enrichment
The genes affected by CNVRs in all Qataris were evalu-
ated by standard pathway analysis against the KEGG
pathway database using the DAVID bioinformatics suite
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[31–33]. Among the top 15 pathways enriched for by
genes affected by all CNVs in Qataris, we observed several
of potential concern for public health (Table 3). These in-
cluded genes involved in starch and sugar metabolism, in
the insulin signaling pathway, and in type I and type II
diabetes mellitus (Additional file 1: Figure S5A-E). Among
these genes was the amylase enzyme AMY1, for which de-
creased copy number was previously shown to be associ-
ated with obesity [34]. Of interest, 47 of 97 individuals in
the cohort had type 2 diabetes (27 Q1, 10 Q2 and 10 Q3),
but there was no statistical enrichment for any of these
CNVs in obese or diabetic individuals vs controls. This
may be due to the low power in small sample size, com-
bined with the possibility that individuals labeled as
controls have yet to develop diabetes due to their young
age at time of assessment (cohort average age 42 years,
with >50 % <40 year). We also observed nominal enrich-
ment in other medically relevant pathways, including drug
metabolism and non-small cell lung cancer (Table 3). To-
gether, these observations suggest that CNVs in this popu-
lation may affect public health by contributing to the
burden of chronic disease in the population and should be
assessed systematically in a larger cohort to establish
power and assess significance.
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Fig. 2 Probability distributions of CNVs by frequency and size in each copy number class in 97 Qataris. Density curves showing the probability
(y-axis) of a given individual from each of the 3 subpopulations having a certain number of CNVs (a-d) or a certain cumulative size of the
genome affected by CNVs (e-h) in each copy number class (a, e. CN = 0; b, f. CN = 1; c, g. CN = 3; d, h. CN = 4+). All p -values are calculated
using the ANOVA-Tukey method. Black trace – Q1, Blue trace - Q2, Red trace – Q3
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Table 2 Functional Annotation of CNV Regions in the Qatari Genetic Subpopulationsa




Overlap DGV Novel Novel genic Promoter site Transcription factor
binding site
Q1 – 0 – homozygous
deletions
341 228 113 2 8 8 322 19 7 20 127
1 – heterozygous
deletions
3,316 2,151 1,165 19 76 83 3,091 225 97 248 1,321
3 – duplication 2,161 1,121 1,040 196 182 223 2,045 116 48 509 980
4 – amplification 463 290 173 12 18 18 445 18 5 54 145
Sub-total Q1 6,281 3,790 2,491 229 284 332 5,903 378 157 831 2,573
Q2 – 0 – homozygous
deletions
293 183 110 1 11 11 287 6 1 14 109
1 – heterozygous
deletions
2,470 1,598 872 15 65 70 2,350 120 53 172 879
3 – duplication 1,760 913 847 156 124 157 1,694 66 28 409 748
4 – amplification 434 268 166 11 17 17 422 12 5 52 143
Sub-total Q2 4,957 2,962 1,995 183 217 255 4,753 204 87 647 1,879
Q3 – 0 – homozygous
deletions
267 174 93 0 18 8 262 5 2 16 101
1 – heterozygous
deletions
2,858 1,902 956 13 61 65 2,726 132 45 176 1,046
3 – duplication 1,835 977 858 148 122 141 1,754 81 29 407 772
4 – amplification 462 284 178 19 23 24 443 19 9 61 146
Sub-total Q3 5,422 3,337 2,085 180 224 238 5,185 237 85 660 2,065
Total 16,660 10,089 6,571 592 725 825 15,841 819 329 2,138 6,517
aCNVRs were annotated as described in Methods. Distribution of CNVs is summarized by CN class within each subpopulation and by functional class including: Total number = all CNVRs detected; nongenic = CNVRs
that do not overlap coding regions; genic = CNVRs that overlap genes; miRNA = CNVRs that overlap microRNAs; Mendelian disease genes = CNVRs that include at least 1 known Mendelian disease gene; DGV = CNVRs
that overlap a known CNV from the database of genomic variants; novel = CNVRs that do not overlap known CNVs and are unique to Qataris; novel genic = the subset of novel CNVRs that overlap at least 1 gene;














CNVs affecting Mendelian disease genes
In order to determine whether CNVs may also play a role
in rare disease in Qataris, we compared all genes affected
by CNVRs to the database of Online Mendelian Inher-
itance in Man (OMIM). In all three subpopulations, ap-
proximately 10 % of all genic CNVRs affected at least 1
OMIM gene (Table 2). The OMIM database contains a
combination of disease causing genes, as well as disease-
associated genes and genes affecting polymorphic traits.
Because we were most interested in genes that have suffi-
cient evidence of disease-causality from the literature, we
re-annotated all CNV-encompassed OMIM genes based
on their published role in causing disease, and then manu-
ally curated all putative OMIM-gene-containing CNVRs
to determine the exact number of exons that were likely
to be disrupted by each CNV (contained within the CNVs’
breakpoints).
The focus was on the subset of CNVRs most likely to
have a functional impact on a gene. These include deletions
affecting any number of exons and duplications that either
encompass at least one entire gene (increased dosage) or
are internal to the gene (possibly disrupting protein transla-
tion frame). We therefore eliminated from consideration all
intronic events as well as duplications that were partially
genic (one breakpoint extending past the first or last exon
with the other breakpoint inside the gene). We then split
the list of OMIM-affected genes into two groups: (1) genes
in which CNVRs had been previously reported; and (2)
genes affected by novel, Qatari-specific CNVRs. In the
former group, we found a total of 46 disrupted disease-
causing genes (13 in deletions and 33 in duplications)
affected by 40 unique CNVR loci (13 deletions and 27 du-
plications) (Table 4). These CNVRs had variable distribu-
tion among the 3 subpopulations, with most being specific
to one or two populations while only 9 were observed in all
3 subpopulations. Thus, the majority of Mendelian-disease-
gene containing CNVRs is population-specific, and may
predispose to disease due to high levels of intra-population
mating. Further, though these CNVRs are marked as previ-
ously reported due to overlap with CNVRs in the database
of genomic variants (DGV) [35], it is possible due to the
variable breakpoints of CNVs deposited in the DGV that
these Qatari CNVs affect different exons or occur at a
higher frequency in this population than the rest of the
world.
We also examined OMIM-gene-containing CNVRs
that were novel to Qataris. To determine novelty here,
Qatari CNVRs were compared to CNVRs reported in
the 1000 Genomes Phase I [36] study that were detected
through next-generation sequencing with high-resolution
breakpoints. Only 14 Qatari CNVRs passed this filter,
reflecting the high diversity of populations represented in
the 1000 Genomes data. These CNVRs included 9 deletions
and 5 duplications (Table 5). Five of these CNVRs were
Qatari sub-population-specific, while nine were shared by 2
or more sub-populations. Of the shared CNVRs, there were
four deletions – one of exon 47 in the Chediak-Higashi
syndrome gene LYST (lysosomal trafficking regulator gene)
observed in one Q1 and one Q2 individuals, one in the glu-
taric acidemia gene ETFDH (electron transfer flavoprotein
dehydrogenase) in one Q1 and one Q2 individuals, one in
exons 2 to 3 of the alpha-methyl acetoacetic aciduria gene
Table 3 Top 15 KEGG Pathways Enriched in Genes Affected by CNVs in Qatarisa
Kegg pathway Number of genes Fold-enrichment p value
Notch signaling pathway 16 2.7 4.4 × 10−4
Starch and sucrose metabolism 14 2.6 1.5 × 10−3
Focal adhesion 39 1.5 6.4 × 10−3
mTOR signaling pathway 14 2.1 1.1 × 10−2
Purine metabolism 30 1.5 1.6 × 10−2
Antigen processing and presentation 19 1.8 1.4 × 10−2
Axon guidance 25 1.5 3.2 × 10−2
Type II diabetes mellitus 12 2 3.0 × 10−2
Drug metabolism 14 1.8 4.4 × 10−2
Extracellular matrix - receptor interaction 17 1.6 6.0 × 10−2
Type I diabetes mellitus 10 1.9 7.6 × 10−2
Non-small cell lung cancer 12 1.8 7.2 × 10−2
Insulin signaling pathway 24 1.4 8.2 × 10−2
Metabolism of xenobiotics by cytochrome P450 13 1.7 7.0 × 10−2
Maturity onset diabetes of the young 7 2.2 8.7 × 10−2
aAll genes affected by CNVs in Qataris were analyzed by DAVID bioinformatics resources for KEGG pathways. Number of genes in each enriched KEGG Pathway,
along with the fold-enrichment within each pathway and a p value for the significance of enrichment
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Table 4 Qatari Genetic Subpopulation-specific Distribution of Known CNV Regions Deletions Affecting Known Mendelian Disease
Genesa
Disease (MIM number) Gene Exons
affected
CHR Start End Size Q12 Q22 Q32
Deletion
Age related macular degeneration (603075) HMCN1 31/107 1q31.1 185979151 185985000 5849 - <1 % -
Chediak-Higashi syndrome (214500) LYST 47/53 1q42.3 235854998 235858929 3931 <1 % <1 % -
Dystonia 16 (612067) PRKRA 6-7/7 2q31.2 179296981 179300871 3890 >10 % 1-10 % 1-10 %
Glutaric acidemia IIC (231680) ETFDH 1/13 4q32.1 159591175 159594157 2982 <1 % 1-10 % -
Distal myopathy (606070) MATR3 16-17/18 5q31.2 138661971 138665031 3060 1-10 % 1-10 % <1 %
Prostate cancer (176807) MSR1 5-10/10 8p22 15945301 16023600 78299 - <1 % -
Alpha-methylacetoacetic aciduria (203750) ACAT1 2-3/12 11q22.3 108002099 108004927 2828 <1 % - <1 %
Keutel syndrome (245150) MGP 1-5/5 12p12.3 15035821 15051689 15868 1-10 % - -
von Willebrand disease (193400) VWF 4-5/52 12p13.31 6218203 6225614 7411 1-10 % 1-10 % -
Adams-Oliver syndrome (614219) DOCK6 15-28/48 19p13.2 11332570 11350981 18411 1-10 % 1-10 % <1 %
Nephrotic syndrom (256300) NPHS1 21-22/29 19q13.12 36328501 36331200 2699 - <1 % -
Bleeding disorder, platelet-type (614201) GP6 7-8/8 19q13.42 55523566 55526400 2834 - - <1 %
Essential hypertension (14550) PTGIS 9-10/10 20q13.13 48124290 48128451 4161 <1 % - -
Duplication
Corneal dystrophy (136800) COL8A2 2/2 1p34.3 36559621 36565584 5963 - - <1 %
Cerebellar ataxia (614756) CAMTA1 11/23 1p36.23 7735380 7742501 7121 1-10 % >10 % -
Peroxisome biogenesis disorder (614870) PEX10 1-6/6 1p36.33,p36.32 2283844 2539006 255162 >10 % - -
Holoprosencephaly-9 (610829) GLI2 10-13/13 2q14.2 121739875 121747372 7497 1-10 % - <1 %
N-acetylaspartate deficiency (614063) NAT8L 1-3/3 4p16.3 2035597 2071655 36058 >10 % >10 % 1-10 %
Primary ciliary dyskinesia 3 (608644) DNAH5 48-50/79 5p15.2 13791701 13795151 3450 1-10 % - -
Bone marrow failure (614742) TERT 4-15/15 5p15.33 1230427 1255520 25093 1-10 % - -
Recessive spastic paraplegia (613647) AP5Z1 1-17/17 7p22.1 4805669 4877956 72287 >10 % >10 % >10 %
Progressive myoclonic epilepsy (611726) KCTD7 1-5/5 7q11.21 66071436 66132291 60855 - - <1 %
5-oxoprolinase deficiency (260005) OPLAH 1-28/28 8q24.3 144773296 145216604 443308 >10 % >10 % 1-10 %
Amelogenesis imperfecta, type 3 (130900) FAM83H 1-5/5 8q24.3 144773296 145216604 443308 >10 % >10 % 1-10 %
Muscular dystrophy with epidermolysis
bullosa (226670)
PLEC 1-32/32 8q24.3 144773296 145216604 443308 >10 % >10 % 1-10 %
Acrodermatitis enteropathica (201100) SLC39A4 1-12/12 8q24.3 145278809 145771012 492203 >10 % - -
Rothmund-Thomson syndrome (268400) RECQL4 1-22/22 8q24.3 145278809 145771012 492203 >10 % - -
Myasthenic syndrome (608931) MUSK 2-3/13 9q31.3 113439201 113451401 12200 <1 % <1 % -
Autosomal dominant mental retardation
(614254)
GRIN1 1-21/21 9q34.3 139887971 140232124 344153 >10 % >10 % >10 %
Hypophosphatemic rickets with
hypercalciuria (241530)
SLC34A3 1-13/13 9q34.3 139887971 140232124 344153 >10 % >10 % >10 %
Recessive deafness (613307) TPRN 1-4/4 9q34.3 139887971 140232124 344153 >10 % >10 % >10 %
Recessive mental retardation (614202) MAN1B1 1-14/14 9q34.3 139887971 140232124 344153 >10 % >10 % >10 %
Osteogenesis imperfecta, type V (610967) IFITM5 1-2/2 11p15.5 280817 312896 32079 - - 1-10 %
Famililial hyperproinsulinemia (MODY)
(613370)
INS 1-2/2 11p15.5 2179313 2194175 14862 1-10 % 1-10 % 1-10 %
Segawa syndrome (605407) TH 1-14/14 11p15.5 2179313 2194175 14862 1-10 % 1-10 % 1-10 %
Primary congenital glaucoma (613086) LTBP3 1-10/10 11q13.1 65305964 65407963 101999 >10 % - -
Pyruvate carboxylase deficiency (266150) PC 13-18/22 11q13.2 66617727 66629986 12259 1-10 % - -
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ACAT1 (acetyl-coA acetyltransferase 1) in one Q1 and one
Q3 individuals, and one in exons 1-7 of the Gitelman Syn-
drome gene solute carrier 12, family member 3 (SLC12A3)
observed in one Q1 and two Q2 individuals. All of these
disorders are autosomal recessive and these deletions puta-
tively truncate the genes and therefore predispose these
subpopulations to these diseases if present in homozygous
state. Additionally, there was one disease-gene affecting
CNVR that was present in 7 individuals from all three
subpopulations (5 Q1, 1 Q2 and 1 Q3), a 3 kb internal
duplication of exons 13-14 of PMS2 (post-meiotic seg-
regation increased in S. cerevisiae 2), a gene in which
mutations in both alleles are observed in patients with
hereditary nonpolyposis cancer and mismatch repair
cancer syndrome. Additionally, 3 other individuals (2 Q1,
1 Q2) had a smaller (2.7 kb) deletion affecting the same
exons. In total, 10 individuals (10.3 % of the cohort) had a
CNV not present in public databases that putatively dis-
rupts PMS2. Of note, colorectal cancer is the second most
common cancer in Qatari males and third most common
in females [37]; whether this gene contributes to the
burden of colorectal cancer in this population is currently
not known.
Qatari CNVs affecting known disease cytobands
There has been substantial evidence implicating CNV
mutations in a range of diseases, including obesity, con-
genital heart disease and a variety of neuropsychiatric
disorders [13–24, 31]. In particular, there is a growing
body of literature suggesting rare but recurrent CNVs at
several loci are responsible for a proportion of these
diseases in sporadic cohorts [14, 18, 20, 21, 23, 38]. We
sought to determine the burden of CNVs by chromosomal
cytoband to detect any enrichment in Qatari Arabs over
global cohorts. Because the database of genomic variants
(DGV) contains >200,000 CNVRs from >200 studies [35]
detected using a wide variety of low- and high-resolution
platforms, we limited this comparison to CNVRs detected
by an equally high-resolution platform (next-generation se-
quencing) in the diverse 1000 Genomes Project phase I
study (1000Gp1) [36]. All CNVRs reported in the 1000Gp1
dataset and from our study in each of the 3 Qatari subpop-
ulations were annotated by cytoband. Of 862 cytobands in
the 24 human chromosomes, 769 contained CNVRs in the
1000 genomes samples; of these, 741 had CNVRs in Q1,
708 in Q2, and 735 in Q3. There were several cytobands
observed in which unique CNVRs were observed at a much
higher frequency (1.5 to 10 times more non-overlapping
CNVRs per cytoband) in any one of the Qatari subpop-
ulations than in the phase I data. Among the top 10
cytobands (Table 6) with the highest enrichment were sev-
eral disease-associated hotspot loci, including: 1q21.1 (Q1
p = 1.6 × 10−16, Q2 p = 9.67 × 10−22 and Q3 p = 2.4 × 10−20),
in which recurrent CNVs have been observed in patients
with schizophrenia and congenital heart disease; 5q13.2
(p = 3.4 × 10−11, 8.2 × 10−14 and 1.8 × 10−11 in Q1, Q2 and
Q3 respectively), a locus associated with neurological disor-
ders and alcohol dependence, 16p11.2 (p = 7.1 × 10−9, 8.1 ×
10−12; and 1.2 × 10−11 in Q1, Q2 and Q3 respectively), a
locus highly associated with autism, schizophrenia and
childhood obesity; and 1p36.33 (p = 2.87 × 10−7 in Q3 only),
a locus associated with disorders of sexual development
Table 4 Qatari Genetic Subpopulation-specific Distribution of Known CNV Regions Deletions Affecting Known Mendelian Disease
Genesa (Continued)
Mitochondrial myopathy and sideroblastic
anemia (600462)
PUS1 1-4/6 12q24.33 132369172 132424944 55772 >10 % - -
GABA-transaminase deficiency (613163) ABAT 1-16/16 16p13.2 8723887 8875529 151642 - - <1 %
Progressive myopathy with developmental
delay (613076)
GFER 1-3/3 16p13.3 2003399 2285357 281958 >10 % 1-10 % -
Polycystic kidney disease, adult type I
(173900)
PKD1 1-46/46 16p13.3 2003399 2285357 281958 >10 % 1-10 % -
Tuberous sclerosis 2 (606690) TSC2 1-23/23 16p13.3 2003399 2285357 281958 >10 % 1-10 % -
Tyrosinemia, type II (276600) TAT 1-12/12 16q22.2 71541001 71622751 81750 - - <1 %
Cataract (610202) MAF 1-2/2 16q23.2 79620742 79638078 17336 1-10 % 1-10 % 1-10 %
Huntington disease-like 2 (606438) JPH3 2/5 16q24.2 87720933 87724383 3450 1-10 % <1 % <1 %
Knobloch syndrome (267750) COL18A1 1-41/41 21q22.3 46853110 46974756 121646 - 1-10 % 1-10 %
Bethlem myopathy (158810) COL6A1 3-35/35 21q22.3 47390167 47435702 45535 >10 1-10 1-10 %
Recessive familial candidiasis (613953) IL17RA 1/1 22q11.1 17595746 17616510 20764 1-10 % - 1-10 %
aGenes affected by CNVRs in each subpopulation were looked up in the database for Online Mendelian Inheritance in Man (OMIM) for confirmed role in disease.
Disease name, MIM number (OMIM identifier) and gene appear in the first two columns, followed by CNVR-centric information and sub-population-centric data.
Start-End: coordinates of CNV containing OMIM gene; Deleted/Duplicated exons: exons from each gene within the boundaries of the deletion or duplication
2Q1, Q2 and Q3: Percentage of individuals in each subpopulation carrying this CNVR. “-” indicates CNVR not present in this subpopulation
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OMIM gene name Exons
affected










Age-related macular degeneration 603075 HMCN1 Hemonectin 31/107 - Deletion 1q31.1:185979151-
185985000
5849 0 1 0
Chediak-Higashi syndrome 214500 LYST Lysosomal trafficking
regulator
47/53 - Deletion 1q42.3:235854998-
235858929
3931 1 1 0
Glutaric acidemia IIC 231680 ETFDH Electron transfer
flavoprotein
dehydrogenase
1/13 C4orf46 Deletion 4q32.1:159591175-
159594157
2982 1 1 0
Hereditary nonpolyposis colorectal
cancer, type 4
614337 PMS2 Post-meiotic segregation





2699 2 1 0
Microcephaly 1, autosomal
recessive
251200 MCPH1 Microcephaly 1 14/14 - Deletion 8p23.1:6493670-
6501582
7912 1 0 0
Deafness, autosomal dominant 608641 GRHL2 Grainy-head like 2 8/16 - Deletion 8q22.3:102604016-
102619491
15475 0 1 0
Alpha-methylacetoacetic aciduria 203750 ACAT1 Acetyl-CoA
acetyltransferase 1
2-3/12 - Deletion 11q22.3:108002099-
108004927
2828 1 0 1
Gitelman syndrome 263800 SLC12A3 Solute carrier family 12,
member 3
1-7/26 NUP9, miR-138-2 Deletion 16q13:56857680-
56905458
47778 1 2 0
Essential hypertension 145500 PTGIS Prostaglandin I2 synthase 9-10/10 - Deletion 20q13.13:48124290-
48128451







TWIST1 Twist basic helix-loop-







7107 1 0 0






81750 0 0 1








7497 2 0 1
Hereditary nonpolyposis colorectal
cancer, type 4
614337 PMS2 Post-meiotic segregation







3149 5 1 1






12200 1 1 0
aQatari CNVRs were compared to CNVRs from the 1000 Genomes Phase I study (n = 1092) [25] that were generated using next-generation sequencing technologies. Only 14 CNVRs were novel, including 9 deletions
and 5 duplications. OMIM disorder – name of disorder as it appears in the OMIM database. MIM number – OMIM identifier. Del/Dup – Whether CNVR is a deletion or duplication (full or internal). Other affected














and obesity [39–43]. CNVRs in these loci may contribute
to the collective burden of these disorders in the Qatari
population.
Determining tagging probes for Qatari CNVRs
The Illumina OMNI2.5 M array was developed as a global
population-based genotyping tool to integrate variation
down to minor allele frequency (MAF) >2.5 % from the
diverse populations represented in the 1000 Genomes
Project [36]. We first sought to estimate the utility of
the Illumina OMNI 2.5 M array for studying the Qatari
population. To assess the amount of “informative” SNPs
on the OMNI2.5 M array in this population, we used
genotypes from a total of 108 Qataris genotyped on this
platform. The OMNI 2.5 M SNPs were first pruned for
those that had a call in at least 90 % of the 108 individuals
(i.e., at most 11 individuals with “no calls”), which resulted
in 2,368,880 (>99.5 % of all SNPs). Surprisingly, of these,
412,839 SNPs (17.4 %) were monomorphic (MAF = 0 %)
in 108 Qataris. Additionally, 676,116 (28.5 %) had a MAF
Table 6 Top 10 Cytobands in Which Qatari Genetic Subpopulations’ CNVRs were Observed at a Significantly Higher Frequency than





Q1, Q2 or Q3
count
p value Diseases associated with cytoband
Q1 1q21.1 10 55 1.60 × 10−16 Schizophrenia; congenital heart disease
9q21.11 5 42 1.06 × 10−14 -
5q13.2 6 35 3.43 × 10−11 Neurologic disorders; alcohol
dependence
9p11.2 17 49 8.97 × 10−11 -
16p11.2 23 50 7.10 × 10−9 Autism; schizophrenia; obesity
10q11.22 7 29 2.45 × 10−8 -
9p12 14 38 2.66 × 10−8 -
8p11.1 2 20 7.14 × 10−8 -
9p13.1 8 29 7.55 × 10−8 -
7q11.1 3 20 3.66 × 10−7 -
Q2 1q21.1 10 59 9.67 × 10−22 Schizophrenia; congenital heart disease
5q13.2 6 36 8.21 × 10−14 Neurologic disorders; alcohol
dependence
9q21.11 5 33 4.22 × 10−13 -
16p11.2 23 51 8.07 × 10−12 Autism; schizophrenia; obesity
9p11.2 17 44 1.17 × 10−11 -
7q11.1 3 25 8.91 × 10−11 -
8p11.1 2 20 3.77 × 10−9 -
7q11.21 35 53 5.43 × 10−9 -
10q11.22 7 26 8.97 × 10−9 -
9p12 14 30 1.76 × 10−7 -
Q3 1q21.1 10 60 2.04 × 10−20 Schizophrenia; congenital heart disease
9q21.11 5 37 7.23 × 10−14 -
9p11.2 17 48 6.27 × 10−12 -
16p11.2 23 54 1.26 × 10−11 Autism; schizophrenia; obesity
5q13.2 6 33 1.83 × 10−11 Neurologic disorders; alcohol
dependence
10q11.22 7 29 3.10 × 10−9 -
7q11.1 3 21 3.00 × 10−8 -
22q11.1 7 25 1.20 × 10−7 -
8p11.1 2 18 1.24 × 10−7 -
1p36.33 12 30 2.87 × 10−7 Disorders of sexual development; obesity
aAll CNVRs detected in Q1, Q2 and Q3 Qataris as well as all CNVRs in the Database of Genomic Variantsfrom the 1000 Genomes Project Phase I [25] data were
annotated for which chromosome and cytoband they affected. Fisher’s exact test was used to evaluate enrichment or depletion of CNVRs from a specific
cytoband, corrected p value for significance (<6.7 × 10−6)
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of less than 1 % in Qataris, and 1,028,842 (43.4 %) have a
minor allele frequency of less than 5 %. Therefore, in total
less than 60 % of the SNPs on the OMNI 2.5 M array ad-
equately sample common variants in Qataris (Additional
file 1: Table S2).
Nevertheless, we attempted to assess whether a subset
of these SNPs tag common CNVs in this population,
which could be useful for imputation of Arab-population
CNVs from genetic data using this or similar arrays in fu-
ture studies. In order to increase specificity, we focused on
1193 common deletions (deleted allele observed at least 4
times) across the 97 individuals in this study, and investi-
gated the pairwise correlation between the deletion CNV
and all SNPs within 500 kb either side of the deletion’s
breakpoints. As expected, while 1168 CNVs (98 %) had at
least 1 SNP within 500 kb of either breakpoint, the major-
ity of SNPs from the OMNI 2.5 M array neighboring
CNVs did not adequately tag the deletion allele, with the
majority of SNPs (~62 %) having a maximum r2 < 0.5
(Fig. 3a). In fact, only 318 of 1193 deletions were tagged
by at least one SNP at a Pearson correlation of r2 > 0.7, of
which only 195 (~16 %) were tagged at r2 > 0.9 (Additional
file 1: Table S3). Further, of the 422 genic subset of CNVs
within the 1193 deletions, only 35 % were tagged by an
array SNPs with a correlation r2 > 0.5, and less than 7 %
appeared in complete LD (r2 > 1.0). Therefore, the ma-
jority of deletions common to the Qatari population
were poorly tagged by the high density OMNI 2.5 M
array, which could pose significant challenges to using
this or other commercial arrays to genotype CNVs in
Arab populations.
In order to rectify this issue, we sought to determine a
set of SNPs that could better tag these CNVs by relying on
genotypes obtained from the whole genome sequencing
of these 97 individuals (described in methods). All ~21
million high-quality variants detected in 97 individuals
were first pruned for those within 500 kb upstream and
downstream of each CNV breakpoint, and then LD
measured between each CNV and all neighboring SNPs
within this window. There was a highly significant im-
provement of up to 250 % for all CNVs and almost 1.5
times that (367 %) for genic CNVs at r2 = 1 (Fig. 3b and
Additional file 1: Table S3). With whole genome se-
quencing SNPs, we observed >70 % of all deletions be-
ing tagged by at least one SNP at an r2 > 0.5, and over
50 % at r2 > 0.8, suggesting these could be imputed in
future experiments from sequence data. In order to facili-
tate the design of new genotyping arrays that tag CNVs
in this population, we include a list of deletion-tagging
genotypes at SNPs tagging 806 CNVs at r2 > 0.5 (Additional
file 1: Table S4). We also include this information at greater
detail in the accompanying Additional file 2 containing
the complete CNV dataset with all functional annotation
in 97 Qataris.
Discussion
This study uses two primary datasets called by four separate
algorithms to generate the first catalog of high-resolution
copy number variants within Qataris, a population that
shares significant genetic ancestry with the neighboring
populations of the Arabian Gulf who remain under repre-
sented in public databases. Our analysis reveals several not-
able features of copy number changes in this region of the
world. First, CNV distribution patterns among members of
the different Qatari subpopulations is concordant with their
cultural and demographic histories, where higher consan-
guinity in Q1 and Q2 populations has led to a significantly
higher number of homozygous deletions vs the more
b Subset of 422 common genic deletions tagged by 
SNPs within a 500 kb window at a given pairwise 
r2 value on the 2.5M Omni array vs SNPs detected 
from whole-genome sequencing data
a Subset of 1193 common deletions tagged by SNPs within a 
500 kb window at a given pairwise r2 value on the 2.5M Omni 
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Fig. 3 All SNPs within 500 kb of start and end breakpoints of 1,193
deletions were used to detect for each deletion a SNP with the
maximum pairwise LD correlation. This was done both for a. all 1193
CNVs and b. for only 422 Genic CNVs. In both cases, the WGS SNVs
significantly outperformed the OMNI2.5 M SNPs, especially at higher
r2 values. WGS-SNVs: Whole genome sequencing detected variants
(●). OMNI2.5 M-SNPs: SNPs present on the OMNI2.5 M array (Ο)
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diverse Q3 individuals. Notably, these deletions are larger
in size, and may be useful for studies of the effect of
gene-loss on individual fitness, similar to studies of loss
of function mutations in large but seemingly healthy
cohorts. Further, a large proportion of CNVRs across
all 3 Qatari subpopulations affect coding or functional
elements (with slight depletion in Q3 vs either Q1 or
Q2), including known rare, severe disease genes and
loci. Of particular interest is the increased burden of
CNVs in certain KEGG pathways relevant to population
health in Qatar and in the region, such as diabetes, in-
sulin signaling and metabolism.
While all 97 individuals analyzed here are phenotypic-
ally “control” adults, the possibility that the CNVs they
carry might be associated with disease cannot be ruled
out. CNVs have been shown to play a role both in popu-
lation diversity and in pathophysiology, where increased
or decreased gene dosage may be responsible for human
phenotypic variability as well as complex behavioral
traits and disease (reviewed in [17, 44–46]). Indeed, we
observe a significantly higher burden of CNVs in cyto-
bands linked to known, rare syndromic disorders. Thus,
the Qatari population could be at risk for any of these
CNV-related disorders under a two-hit model, where in-
complete penetrance and variable expressivity may de-
pend on a second insult, possibly a point mutation, at an
interacting locus [47]. Further, we found a number of
CNVs that were shared within the Qatari population
(but novel to public databases) affecting severe Mendelian
disease causing genes, including recurrent hits (both
deletions and duplications) in PMS2, a gene that is often
mutated in colon cancer, the second most prevalent can-
cer in Qatar [37]. These observations will be informative
in the design of the next generation of clinical copy num-
ber arrays for use with this population.
A distinctive feature of this study is in combining
high-resolution CNV calls from whole genome sequencing
with the traditional CNV calls from genotyping array data,
which demonstrated a non-trivial number of CNVs de-
tected exclusively by only one platform. This held true
despite high specificity thresholds implemented to re-
duce spurious calls, suggesting that relying on only
one of these platforms risks eliminating a substantial
amount of the underlying variation. This hybrid strat-
egy uncovered approximately 1815 CNVs of size range
2.5 kb to 2 Mb in the median Qatari individual, affect-
ing a total of ~28 Mb of genomic DNA. This is slightly
lower than previously published high-resolution stud-
ies that estimate CNVs affect up to 40 Mb of genomic
DNA [10, 25], and may be due to a combination of
our higher minimum size thresholds (2.5 kb vs 500 bp
used in other studies) and the strict specificity criteria
we employed, which eliminated all singletons. Neverthe-
less, we observed that up to 40 % of CNVRs affected genic
content, suggesting these could contribute to key traits yet
to be fully understood in the general population.
As an additional analysis, we determined the useful-
ness of the OMNI2.5 M array to genotype CNVs in this
population. The performance of this array was relatively
poor, with <35 % of CNVs tagged at r2 > 0.5. We decided
instead to leverage the genotypes obtained from whole
genome sequencing of these same individuals and found
substantial improvements to discovering tagging SNPs
for these population-level deletions (included in the whole
CNV dataset released as Additional Data accompanying
this study). These SNPs could be included in future arrays
designed to genotype Arab cohorts, and used to impute
these deletions in Qatari or ancestrally similar Gulf Arabs.
This study, with its small population size, is under-
powered to discover any significant effect of CNVRs on
common disease in the population. However, it provides
the first step in creating a database of Qatari-specific
CNVRs that sets the landscape for future research to as-
sess rare and common CNVs in a much larger Qatari
cohort. We suspect that the Qatari population’s unique
burden of rare and chronic disease will provide a strong
platform for discovery of functional CNVs in future
studies. This is especially critical, for example, in the
burden of deletions disrupting known disease genes (e.g.
those in OMIM), which may appear in homozygous
state in the highly consanguineous Qatari population.
Indeed, of particular interest for human disease studies
is the significantly higher proportion of homozygous de-
letions in Q1s and Q2s, which could shed light on the
subset of the genome that is “dispensable” for normal
human development into adulthood due to loss of gene
function [48–50]. In this study, we find 200 genes that
are affected by homozygous deletions, yet appear to
cause no overt phenotypic abnormalities in this group of
97 seemingly healthy adults.
In recent years, each of genotyping arrays, array-CGH
microarrays, and next-generation sequencing have all
been implemented successfully to detect structural vari-
ation in human cohorts (reviewed in [45]). While the
majority of studies continue with HapMap cohorts, there
has been a recent increase in the number of reports
from non-HapMap populations, the majority of which
are still ancestrally similar to pre-existing HapMap pop-
ulations (e.g., East Asian populations) [51–53]. To date,
however, there has been no systematic characterization of
CNVs in Gulf Arabs, a population witnessing a growth in
clinical genomics testing but whose ancestry is not ad-
equately represented in current HapMap and 1000 Ge-
nomes populations. We present this study as the first
systematic approach that makes available data on a large
number of CNVs detected from both genotyping and
sequencing platforms in this previously under-explored
population, and believe the frequency of CNVs reported
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in this study could be used to assess the pathogenicity of
clinically detected CNVs in Gulf Arab patients that appear
novel to public databases. Thus, this high-resolution map
of CNVs in Qataris is likely representative of ethnically
similar Gulf-Arabs, and the accompanying database will in-
form future studies with larger cohorts aimed at under-
standing the unique population history in this region and
the interpretation and analysis of clinically-observed CNVs
in patients.
Conclusions
Overall, there is little doubt that some proportion of dis-
ease burden in certain patient cohorts can be explained
by CNVs [17, 44–46]. As detection methods continue to
improve, so will the discovery of new genes and loci whose
deletion or duplication could lead to morbid clinical phe-
notypes in specific populations. This kind of population
specificity will have detrimental effects on the design of
population-specific clinical CHG-arrays, and on the in-
terpretation and assignment of pathogenicity of CNV
findings in individuals from different ethnic populations
[25, 51–54]. This issue is of special relevance to Arabs
in general and Qataris specifically, for whom there is a
paucity of databases of CNVs observed in healthy controls.
In this study, we generate a highly dense catalog of
16,660 CNVRs in a cohort of 97 Qataris, by employing
strict QC criteria for detection of CNVs and by integrat-
ing data from both SNP arrays and NGS technologies to
achieve high-resolution breakpoint annotation for most
variants. We find that ~40 % of these CNVRs affect genic
and functional content, and that >5 % of all CNVs discov-
ered are novel when compared to the well-populated
Database of Genomic Variants [35], and thus represent
polymorphisms in this population that may be misinter-
preted as disease-causing in clinical cases in the absence
of population-matched controls. Interestingly, despite the
small sample size, we observe genes affected by these
CNVRs that function in biological pathways relevant to
population health, including Mendelian disease-causing
genes reported in OMIM.genes involved in diabetes and
carbohydrate metabolism, genes implicated in cancer, as
well as homozygous deletions affecting up to 200 unique
genes in seemingly healthy individuals. These are likely
underestimates resulting from our strict quality filtration
criteria (e.g., eliminating all true singletons and annotating
breakpoints conservatively whenever two CNVs over-
lapped). Nevertheless, these findings pave the way for
follow-up studies in larger cohorts with sufficient power
and phenotypic information to determine their true
contribution to disease burden in this population. Finally,
we leverage the genotypes obtained from next-generation
sequencing to identify SNPs that are at high linkage
disequilibrium with sub-population-specific deletions,
allowing their imputation in future studies of matched
cohorts. This study therefore complements pre-existing
and future next-generation sequencing work in Qataris,
and presents findings which improve our understanding
of CNV prevalence as a class of previously underexplored
variation in this population, and their contribution to
disease in Qataris, and possibly in ethnically similar
Gulf Arabs.
Methods
Study population sample preparation and sequencing
In order to catalog CNVs in the Qatari population, the
genomes of 108 Qataris were deeply sequenced (mean
depth 37X) on the Illumina platform. Human subjects
were recruited and written informed consent was obtained
at Hamad Medical Corporation (HMC) and HMC Primary
Health Care Centers in Doha, Qatar under protocols ap-
proved by the Joint Institutional Review Boards of Hamad
Medical Corporation and Weill Cornell Medical College
in Qatar (protocol # 13-00063). The population of Qatar
includes over 2 million inhabitants, comprised of approxi-
mately 300,000 nationals with roots in Qatar predating
the discovery of oil and gas, and establishment of an inde-
pendent nation in 1970 and the over 1.7 million immigrants
who mostly arrived in the past decade [55]. As selec-
tion criteria for this study, we required that subjects be
third generation Qataris where all ancestors were Qatari
citizens born in Qatar, as assessed by questionnaires.
Cohort selection criteria
Qataris with three or more generations of ancestry can
be divided into 3 genetic subpopulations that reflect the
historical migration patterns in the region: Q1 (Bedouin),
Q2 (Persian-South Asian) and Q3 (Sub-Saharan African)
[2–4]. Proportions of Q1, Q2, and Q3 ancestry were deter-
mined for each Qatari based on TaqMan genotypes (Life
Technologies, Carlsbad, CA) for a panel of 48 ancestry in-
formative SNPs [4]. A STRUCTURE analysis of popula-
tion structure with k = 3 applied to the genotypes was
used to estimate the proportion of ancestry in each of 3
groups (Q1, Q2, Q3). 100 individuals >65 % Q1, Q2 or Q3
were selected for genome sequencing. An additional 8
admixed Qataris who could not be cleanly placed in one
of the three groups were also selected for sequencing.
Next-generation sequencing
Next-generation sequencing was conducted using a se-
quencing library preparation method that eliminates the
need for size selection after shearing and PCR amplification
before ligation of sequencing adapters. Sequencing was
conducted at the Illumina Genome Services sequencing fa-
cility using the HiSeq 2500. Sufficient paired-end 100 bp
reads were generated in order to produce a median of
112 GB of sequence data passing filters and aligned to the
hg19/GRCh37 human reference genome with a median
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insert size of 301 bp, where at least 85 % of bases ≥Q30,
passed filtering steps and were aligned.
Single nucleotide variant calling
In order to identify SNPs in LD with CNVs in Qatar,
SNP genotypes were generated for each Qatari genome.
The Illumina Genome Network generated variant calls
for the autosomal chromosomes for each of the 108
Qatari genomes using the ELAND/CASAVA v1.9 pipe-
line. In order to maximize confidence in the observed
variants, sequence reads were re-mapped and genotypes
were re-called using an in-house population genotyping
pipeline [5]. Reads were realigned to the 1000 Genomes
Project version of the hg19/GRCh37 human reference
genome using BWA 0.5.9 [56] (maximum insert size 3 kb),
and mapped reads were prepared for variant calling using
GATK best practices, including PCR duplicate removal
using SAMTOOLS [57], producing an average of 37x depth
in autosomal chromosomes, with a mean of 98 % of
mappable sites covered per genome. In order to maximize
computational efficiency and integrated call set quality,
calling for the autosomes was restricted to the biallelic
SNPs in the combined set of 21 million segregating auto-
somal SNPs observed at least once in 108 Qatari genomes
by the CASAVA pipeline. SNP genotypes were called
for all 108 Qatari genomes using GATK [58] as de-
scribed in the “Best practices for variant detection v3”
Broad Institute pipeline [http://www.broadinstitute.org/
gatk/]. Genotypes for each Qatari were also generated
using the Illumina OMNI2.5 M array using Illumina’s
GenomeStudio application.
Copy number variant calling and analysis
Copy number was estimated from two independent pri-
mary data sets generated from the same set of 100 samples:
(1) array hybridization on Illumina’s OMNI2.5 M platform;
and (2) whole genome sequencing. See Additional file 1:
Supplemental Methods for details on data preparation and
quality control.
CNVs called from genotyping and Next Generation
Sequencing (NGS) data
To comprehensively assess the copy number content of
the 100 genomes, CNVs were assessed using four separate
algorithms, two from genotyping and two from NGS data
(Fig. 1). To identify CNVs from SNP genotype intensities,
two calling platforms were used: Illumina GenomeStudio’s
proprietary cnvPartition software, and QuantiSNP v2.0
[27], reviewed in Pinto et al. [59]. To identify CNVs from
NGS, CNV calls were provided by Illumina Genome
Network, and also independently called using cn.MOPS,
which is suited for multi-sample CNV detection in
population-level data [28]. Preliminary QC and minimum
specificity thresholds for CNV calls are described in
greater detail in Additional file 1: Supplementary Methods.
In total, 97 samples passed the strict quality thresholds
and were used for all downstream analyses.
Generating probability density curves of CNV distributions
in the 3 subpopulations
In order to generate a probability density curve for each
of the three subpopulations, we first plotted a histogram
with the number of individuals having a number of CNVs
or cumulative size of CNVs within a given bin. Then,
using the “density” package in R (by calling the function
density(x), where x is the CNV frequency or size bin), the
empirical histogram was transformed into a curve that
best fits the shape of the data, and accurately approxi-
mates the probability that a given individual has a certain
number or size of CNVs. The empirical data is therefore
transformed into a probability density curve, in a manner
similar to the results obtained using the histogram func-
tion (hist(x,probability = TRUE) for getting a probability
histogram and then fitting a curve to it.
Merging population-level CNV regions
To determine population-level CNV Regions (CNVRs),
the population of 97 Qataris were first separated into
their respective subpopulations (57 Q1, 20 Q2, and 20
Q3) using a panel of 48 SNPs previously as described
[2–4]. The CNVs from individuals within each sub-
population were then merged separately to generate
subpopulation-level CNVRs. Details of merging criteria
and breakpoint assignment are found in Additional file 1:
Supplementary Methods.
CNVR annotation and data analysis
Annotating CNVR features
Subpopulation-specific CNVRs were annotated using
Anntools (version 1.1), in which the following genomic
features were annotated against genome build 37 (hg19):
cytobands, genes (and affected exons), microRNAs, tran-
scription factor binding sites and promoter sites. All genes
were also custom-annotated against the Online Mendelian
Inheritance in Man (OMIM) database and manually cu-
rated by critically evaluating the primary literature to dif-
ferentiate disease-causing genes from disease associated
genes and polymorphisms. Disease-causing genes were
further annotated manually to check exactly which exons
were encompassed within each CNV’s breakpoints.
Determining CNVR novelty
CNVR novelty was assessed by comparison to the database
of genomic variants (DGV). In order to compare CNVRs
discovered in Qataris with those in the DGV, DGV CNVRs
were first pruned to keep only high-resolution studies,
matching or exceeding the resolution of CNVs discov-
ered in this study (2.5 M SNP arrays or next-generation
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sequencing). This allowed for higher confidence in break-
point assignment and in deciding whether a CNV in
Qataris was observed previously or not.
CNVR cytoband enrichment
For assessment of cytoband enrichment, CNVRs in each
Qatari subpopulation were compared to CNVRs detected
from the 1000 Genomes Phase I study, representing a very
high-resolution dataset. CNVRs from that study were first
annotated by the cytoband in which they occurred, and
then a basic count was done for the number of unique
CNVRs in each cytoband. Enrichment in the number of
CNVRs affecting a given cytoband in Qataris vs in the
1000Genomes dataset was calculated by Fisher’s test.
CNVR tagging analysis
In order to determine which SNPs on the OMNI 2.5 M
array adequately tag CNVRs observed in the Qatari
population, we selected CNV deletions that were observed
at least 4 times in the population of 97 (MAF ~2 %). The
CNV genotypes were converted to binary format along with
all genotypes for use by PLINK [60]. The PLINK-pairwise-
ld command was used to calculate Pearson’s correlation
between the genotype of each CNV and all neighboring
SNPs ± 500 kb of the CNV’s breakpoints across 97 indi-
viduals. For each CNV, the closest SNP with the highest
r2 value within the 500 kb window was identified.
Similarly, tagging SNPs from the whole genome se-
quencing data were identified for these same deletions.
Whole genome sequencing data from all 97 individuals
were obtained from Illumina PE 100 Sequencing (as
described above). These were pruned for variants within
500 kb upstream and downstream of each CNV, and then
plink was used as before to determine SNPs with the high-
est Pearson correlation (maximum r2 value) within these
windows.
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